{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:44:23Z","timestamp":1774982663319,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-CE18-0011"],"award-info":[{"award-number":["ANR-18-CE18-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Occitanie and University of Toulouse"},{"name":"Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale"},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the University of Toulouse"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Psoriasis vulgaris is a common chronic inflammatory skin disease associated with hyperproliferation and defective differentiation of keratinocytes. Despite new effective treatments using biologicals targeting key cytokines or their receptors, innovative therapeutic approaches remain to be discovered. Here, psoriasis-like imiquimod-induced skin lesions in mice were improved when topically treated with a nano-sized, phosphorus-based dendrimer capped with azabisphosphonate groups, so-called IMD-006, and previously known as ABP dendrimer. This effect was confirmed using\n                    <jats:italic>ex vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vitro<\/jats:italic>\n                    human psoriasis models generated by adding T helper (Th)1-type and Th17-type inflammatory cytokines to skin explants and reconstructed epidermises, in which topically-applied IMD-006 normalized keratinocyte proliferation and differentiation. In 2D keratinocyte cultures, IMD-006 also decreased proliferation whilst promoting differentiation. It was internalized by keratinocytes and distributed to mitochondria. After treatment with IMD-006, changes to the morphology of the mitochondrial network, increases in mitochondrial ROS levels, and co-localization of mitochondria with lysosomes suggest it promotes mitochondrial degradation, a key step in keratinocyte differentiation. Therefore, our results show that IMD-006 could be a promising candidate for the topical treatment of psoriasis.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0343926","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:44:22Z","timestamp":1774979062000},"page":"e0343926","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A phosphorous-based dendrimer targets mitochondria and normalizes the keratinocyte proliferation\/differentiation balance to improve psoriasis"],"prefix":"10.1371","volume":"21","author":[{"given":"Emily","family":"Clement","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranime","family":"Jebbawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelouahd","family":"Oukhrib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Labie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00eblys","family":"Le Moal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Fruchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Cassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-3578","authenticated-orcid":true,"given":"Anne-Marie","family":"Caminade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric-Olivier","family":"Turrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Blanzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-8531","authenticated-orcid":true,"given":"R\u00e9my","family":"Poupot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"pone.0343926.ref001","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"CEM Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"pone.0343926.ref002","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"A Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0343926.ref003","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.clindermatol.2007.08.005","article-title":"The histopathologic spectrum of psoriasis","volume":"25","author":"M Murphy","year":"2007","journal-title":"Clin Dermatol"},{"key":"pone.0343926.ref004","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1100\/tsw.2011.129","article-title":"Anti-inflammatory properties of dendrimers per se","volume":"11","author":"M Hayder","year":"2011","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"pone.0343926.ref005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12951-023-02052-5","article-title":"Dendrimer-conjugated isotretinoin for controlled transdermal drug delivery","volume":"21","author":"T Zhao","year":"2023","journal-title":"J Nanobiotechnology"},{"issue":"9","key":"pone.0343926.ref006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/nano7090251","article-title":"Pro-inflammatory versus anti-inflammatory effects of dendrimers: the two faces of immuno-modulatory nanoparticles","volume":"7","author":"S Fruchon","year":"2017","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"pone.0343926.ref007","article-title":"Curing inflammatory diseases using phosphorous dendrimers","volume":"14","author":"A-M Caminade","year":"2022","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"81","key":"pone.0343926.ref008","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002212","article-title":"A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis","volume":"3","author":"M Hayder","year":"2011","journal-title":"Sci Transl Med"},{"issue":"8","key":"pone.0343926.ref009","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.3390\/molecules18089305","article-title":"An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis","volume":"18","author":"S Fruchon","year":"2013","journal-title":"Molecules"},{"issue":"11","key":"pone.0343926.ref010","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.biomac.5b00643","article-title":"Phosphorus-based dendrimer ABP treats neuroinflammation by promoting IL-10-producing CD4(+) T cells","volume":"16","author":"M Hayder","year":"2015","journal-title":"Biomacromolecules"},{"issue":"3","key":"pone.0343926.ref011","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/acs.biomac.7b01398","article-title":"Three-dimensional directionality is a pivotal structural feature for the bioactivity of azabisphosphonate-capped poly(phosphorhydrazone) nanodrug dendrimers","volume":"19","author":"M Hayder","year":"2018","journal-title":"Biomacromolecules"},{"issue":"6","key":"pone.0343926.ref012","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/molecules23061272","article-title":"The ABP dendrimer, a drug-candidate against inflammatory diseases that triggers the activation of interleukin-10 producing immune cells","volume":"23","author":"S Fruchon","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"pone.0343926.ref013","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1189\/jlb.0608371","article-title":"Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer","volume":"85","author":"S Fruchon","year":"2009","journal-title":"J Leukoc Biol"},{"key":"pone.0343926.ref014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1479-5876-7-82","article-title":"Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy","volume":"7","author":"D Portevin","year":"2009","journal-title":"J Transl Med"},{"issue":"8","key":"pone.0343926.ref015","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.nano.2016.07.009","article-title":"Poly(phosphorhydrazone) dendrimers: yin and yang of monocyte activation for human NK cell amplification applied to immunotherapy against multiple myeloma","volume":"12","author":"M Poupot","year":"2016","journal-title":"Nanomedicine"},{"issue":"2","key":"pone.0343926.ref016","doi-asserted-by":"crossref","DOI":"10.1186\/ar4546","article-title":"Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent","volume":"16","author":"Y Degbo\u00e9","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"pone.0343926.ref017","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/biom10060949","article-title":"An anti-inflammatory poly(phosphorhydrazone) dendrimer capped with AzaBisPhosphonate groups to treat psoriasis","volume":"10","author":"R Jebbawi","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"pone.0343926.ref018","doi-asserted-by":"crossref","first-page":"108689","DOI":"10.1016\/j.celrep.2021.108689","article-title":"NIX initiates mitochondrial fragmentation via DRP1 to drive epidermal differentiation","volume":"34","author":"CL Simpson","year":"2021","journal-title":"Cell Rep"},{"key":"pone.0343926.ref019","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jid.2018.02.035","article-title":"Lysosomes support the degradation, signaling, and mitochondrial metabolism necessary for human epidermal differentiation","volume":"138","author":"CL Monteleon","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"pone.0343926.ref020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.devcel.2015.10.023","article-title":"Network analysis identifies mitochondrial regulation of epidermal differentiation by MPZL3 and FDXR","volume":"35","author":"A Bhaduri","year":"2015","journal-title":"Dev Cell"},{"issue":"1","key":"pone.0343926.ref021","article-title":"Mitochondrial metabolism as a regulator of keratinocyte differentiation","volume":"3","author":"RB Hamanaka","year":"2013","journal-title":"Cell Logist"},{"issue":"12","key":"pone.0343926.ref022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.05.016","article-title":"Evidence for lysosomal dysfunction within the epidermis in psoriasis and atopic dermatitis","volume":"141","author":"K Klapan","year":"2021","journal-title":"J Invest Dermatol"},{"key":"pone.0343926.ref023","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.jid.2021.06.006","article-title":"Impaired autophagy in psoriasis: a new therapeutic target?","volume":"141","author":"S Hailfinger","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"9","key":"pone.0343926.ref024","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2340\/00015555-2724","article-title":"Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice","volume":"97","author":"C B\u00fcrger","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"pone.0343926.ref025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2340\/00015555529498","article-title":"Ultrastructural changes of mitochondria in dithranol-treated psoriatic epidermis","volume":"52","author":"G Swanbeck","year":"1972","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"pone.0343926.ref026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/exd.13831","article-title":"Mitochondrial dysfunction in affected skin and increased mitochondrial DNA in serum from patients with psoriasis","volume":"28","author":"A Therianou","year":"2019","journal-title":"Exp Dermatol"},{"issue":"3","key":"pone.0343926.ref027","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jdermsci.2020.03.009","article-title":"Imiquimod-induced ROS production disrupts the balance of mitochondrial dynamics and increases mitophagy in skin cancer cells","volume":"98","author":"K-C Chuang","year":"2020","journal-title":"J Dermatol Sci"},{"key":"pone.0343926.ref028","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56991","article-title":"Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis","volume":"9","author":"T Benezeder","year":"2020","journal-title":"Elife"},{"issue":"8","key":"pone.0343926.ref029","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1096\/fj.04-2664fje","article-title":"The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria","volume":"19","author":"A McGill","year":"2005","journal-title":"FASEB J"},{"issue":"4","key":"pone.0343926.ref030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0560.1987.tb01335.x","article-title":"Mitochondrial ring-phenomenon of keratinocytes in psoriasis vulgaris after dithranol therapy","volume":"14","author":"H Klug","year":"1987","journal-title":"J Cutan Pathol"},{"issue":"4","key":"pone.0343926.ref031","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/17435390.2014.940406","article-title":"Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer","volume":"9","author":"S Fruchon","year":"2015","journal-title":"Nanotoxicology"},{"issue":"42","key":"pone.0343926.ref032","doi-asserted-by":"crossref","first-page":"17672","DOI":"10.1039\/C5NR03884G","article-title":"Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes","volume":"7","author":"J Ledall","year":"2015","journal-title":"Nanoscale"},{"issue":"9","key":"pone.0343926.ref033","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/biom9090475","article-title":"Biodistribution and biosafety of a poly(phosphorhydrazone) dendrimer, an anti-inflammatory drug-candidate","volume":"9","author":"S Fruchon","year":"2019","journal-title":"Biomolecules"},{"issue":"12","key":"pone.0343926.ref034","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/pharmaceutics12121224","article-title":"Supramolecular and macromolecular matrix nanocarriers for drug delivery in inflammation-associated skin diseases","volume":"12","author":"R Jebbawi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"13","key":"pone.0343926.ref035","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1096\/fj.06-5742com","article-title":"Design of phosphorylated dendritic architectures to promote human monocyte activation","volume":"20","author":"M Poupot","year":"2006","journal-title":"FASEB J"},{"issue":"4","key":"pone.0343926.ref036","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","article-title":"Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics","volume":"20","author":"MA Dickson","year":"2000","journal-title":"Mol Cell Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:44:29Z","timestamp":1774979069000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343926"}},"subtitle":[],"editor":[{"given":"Swati","family":"Jaiswal","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343926","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}